Year archive

Sharp Therapeutics Corp. — 2026 filings

All 39 regulatory filings released by Sharp Therapeutics Corp. (SHRX) in 2026, sourced directly from the official regulator.

39 Filings

2026 Period

2026 filings (39)

Filing	Released	Lang
Material change report - English.pdf Capital/Financing Update	2026-04-24	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-24	English
News release - English.pdf Earnings Release FY 2025	2026-04-18	English
Other material contracts - English.pdf Investor Presentation	2026-04-18	English
Other material contracts - English.pdf Capital/Financing Update	2026-04-18	English
Other material contracts - English.pdf Capital/Financing Update	2026-04-18	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2026-04-18	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2026-04-18	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2026-04-18	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2026-04-18	English
Annual information form - English.pdf Regulatory Filings	2026-04-18	English
Annual information form - English.pdf Regulatory Filings FY 2025	2026-04-18	English
Annual MD&A - English.pdf Management Reports	2026-04-18	English
Annual MD&A - English.pdf Management Reports	2026-04-18	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-04-17	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-04-17	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-04-17	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-04-17	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2026-04-17	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2026-04-17	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-13	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-13	English
Report of Distributions outside Canada (Form 72-503F).pdf Capital/Financing Update	2026-04-13	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-13	English
Material change report - English.pdf Capital/Financing Update	2026-04-13	English
Material change report - English.pdf Capital/Financing Update	2026-04-13	English
Material change report - English.pdf Capital/Financing Update	2026-04-13	English
Material change report - English.pdf Capital/Financing Update	2026-04-13	French
Material change report - English.pdf Capital/Financing Update	2026-04-13	English
News release - English.pdf Regulatory Filings	2026-04-10	English
News release - English.pdf Capital/Financing Update	2026-04-10	English
News release - English.pdf Capital/Financing Update	2026-04-10	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-07	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-07	English
Report of Distributions outside Canada (Form 72-503F).pdf Regulatory Filings	2026-04-07	English
Material change report - English.pdf Capital/Financing Update	2026-04-07	English
Material change report - English.pdf Capital/Financing Update	2026-04-07	English
Material change report - English.pdf Capital/Financing Update	2026-04-07	English
News release - English.pdf Capital/Financing Update	2026-02-02	English